Loading viewer...
investor_presentation
Format: PDF investor_presentation
Atossa Therapeutics is a clinical-stage biopharmaceutical company developing innovative medicines for oncology and infectious diseases, with a focus on breast cancer and COVID-19. The presentation outlines the company's development pipeline including candidates like Endoxifen, AT-301, and AT-H201, along with clinical trial progress and regulatory strategy.
presentation
investor_presentation
32 Pages
Generac Holdings Inc.
investor_presentation
Aurizon Holdings